HuagongsheHuagongshe Chemistry Print Report · For research reference only
Sodium hydride → ethyl 4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]oxy]-1-piperidinecarboxylate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | Ethyl 4-hydroxypiperidine-1-carboxylate | HCID 96394 | — |
| Reactant | 1-(4-Fluorobenzyl)-2-chlorobenzimidazole | HCID 3020241 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | ethyl 4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]oxy]-1-piperidinecarboxylate | HCID 14013304 | 31.5% |
Reaction Steps
To a stirred mixture of 3.5 parts of ethyl 4-hydroxy-1-piperidinecarboxylate and 135 parts of N,N-dimethylformamide was added 1 part of a sodium hydride dispersion 50% and stirring was continued for 2 hours at room temperature. After the addition of 5.2 parts of 2-chloro-1-[(4-fluorophenyl)methyl]-1H-benzimidazole, the whole was further stirred overnight at room temperature. The reaction mixture was poured into ice water and the product was extracted with trichloromethane. The extract was dried, filtered and evaporated. The residue was crystallized from 2,2'-oxybispropane, yielding 2.5 parts (31.5%) of ethyl 4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]oxy]-1-piperidinecarboxylate; mp. 94.0° C. (26).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US04695575 |
| Source dataset | uspto-grants-1987_09 |
| ORD ID | ord-02960a98118b4ed88931ea42f361b320 |
| Source note | uspto-grants-1987_09 |